+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Bioengineered Wound Care: Technology, Products, Indications, Participants & Prospects

  • ID: 1790520
  • Report
  • Greystone Associates
1 of 3
‘Bioengineered Wound Care: Technology, Products, Indications, Participants & Prospects’ is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.

The study is designed to provide drug company decision makers, product developers, tissue engineers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, treatment segments, and commercial opportunities for bioengineered tissue repair and wound care. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

New Tools and Treatments for Wound Management

Bioengineered products are competing in a worldwide market worth billions, and in which improvements in quality-of-life and treatment outcomes continue to be top healthcare industry initiatives. While pricing for these new-generation products represents a significant premium relative to existing wound care products, recent studies indicate their ability to promote healing in otherwise refractory wounds places them on a competitive plane in terms of total cost of treatment.

As further data on patient outcomes becomes available, the number of indications as well as third party payer acceptance of next-generation wound care products is expected to increase, driving growth and market penetration across all major application segments.

Report highlights:

- Analyzes twenty commercial bioengineered tissue repair products, their technology, market impact and future prospects
- Assesses the market position of bioengineered wound care products by indication and segment
- Analyzes key business model and technology issues including manufacturability, point-of-use factors, and product stability.
- Assesses business risk factors and market issues
- Forecasts technology and product developments, and projects market demand by segment through 2015
- Profiles market sector companies, their product development activity, and business strategies
- Evaluates the impact of economic, technology, and regulatory factors on tissue engineered skin substitutes
Note: Product cover images may vary from those shown
2 of 3
Executive Summary

Advanced Wound Care Market Dynamics
- Global Wound Market - the Current Picture
- Industry Structure
- Key Market Segments
- Acute Wounds
- Refractory Wounds & Ulcers
- Surgical Wounds
- Burns
- Competitive Landscape
- Technology Market Drivers
- Demand Factors
- Patient Demographics
- Risk Factors

Bioengineered Wound Care Product Analysis
- Alloderm
- Apligraf
- Biobrane
- Dermagraft
- Epicel
- Excellarate
- Gammagraft
- Graftjacket
- Integra Dermal Template
- Oasis
- PriMatrix
- Pomogran
- Repliform
- Stratograft
- Strattice
- Transcyte
- VCT01

Market Sector Assessments & Opportunities
- Acute Trauma
- Burns
- Ulcers
- Diabetic Ulcers
- Pressure
- Venous Ulcers

Business Sector Strategies and Risks
- Development Stage Transition Factors
- Capitalization and Commercialization
- Enabling Technologies

Market Factors
- Clinical Trial Factors
- FDA Guidelines
- Reimbursement
- Point-of-Care Processing

Market Participant Profiles
Note: Product cover images may vary from those shown
3 of 3


4 of 3